New foundational therapy in heart failure with reduced ejection fraction: should we keep following the 2016 European Society of Cardiology Heart Failure Guideline in 2021?

27 August 2021 (00:00 - 00:00)

Organised by:

Sign in for access options

Sign in to view the resources

Sign in for access options

About the speaker

Doctor Joana Brito

Santa Maria University Hospital CHLN Lisbon Academic Medical Centre, Lisbon (Portugal)

4 More presentations in this session

Presentation thumbnail

Machine learning to aid in the diagnosis of acute heart failure in the emergency department

Mr D. Doudesis (Edinburgh, GB)

Abstract Slides Video

Presentation thumbnail

Implication of sphingolipid metabolism gene dysregulation and cardiac sphingosine-1-phosphate accumulation in heart failure

Miss L. Perez Carrillo (Valencia, ES)

Abstract Slides Video

Presentation thumbnail

Age- and Sex-Specific Rates of Heart Failure and other Adverse Cardiovascular Outcomes in Systemic Sclerosis

Doctor G. Sun (Guangzhou, CN)

Abstract Slides Video

Presentation thumbnail

Applying the ESC 2016, the H2FPEF, and the HFA-PEFF diagnostic algorithms for heart failure with preserved ejection fraction to the general population - a comparative approach

Doctor J. Nikorowitsch (Hamburg, DE)

Abstract Slides Video

Access the full session

Session thumbnail

Highlights from the Young in heart failure

The Event

ESC Congress 2021 - The Digital Experience

27 August - 30 August 2021

You may be interested in

Congress Presentation

Breaking the barriers in guideline-directed medical therapy implementation in heart failure - discussion

Congress Presentation

The role of ICD therapy in heart failure in 2024. What is the holistic approach to treat heart failure?

Congress Session

Guideline-directed medical therapy implementation in special clinical scenarios

ESC 365 is supported by

novartis

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources